BioCapital GP, LLC Samsara, a 10% owner of $MLYS, bought 600,000 shares of the company on 03-13-2025 for an estimated $8,100,000. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 11.8%. Following this trade, they now own 5,674,916 shares of this class of $MLYS stock.
$MLYS Insider Trading Activity
$MLYS insiders have traded $MLYS stock on the open market 10 times in the past 6 months. Of those trades, 3 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $MLYS stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, L.P. RA purchased 1,296,296 shares for an estimated $17,499,996
- SRINIVAS AKKARAJU purchased 600,000 shares for an estimated $8,100,000
- BIOCAPITAL GP, LLC SAMSARA purchased 600,000 shares for an estimated $8,100,000
- DAVID MALCOM RODMAN (Chief Medical Officer) has made 0 purchases and 2 sales selling 30,508 shares for an estimated $458,463.
- JON CONGLETON (Chief Executive Officer) has made 0 purchases and 2 sales selling 33,604 shares for an estimated $372,515.
- ADAM SCOTT LEVY (CFO and Secretary) has made 0 purchases and 3 sales selling 21,514 shares for an estimated $243,867.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MLYS Hedge Fund Activity
We have seen 59 institutional investors add shares of $MLYS stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 1,002,941 shares (+1015.8%) to their portfolio in Q4 2024, for an estimated $12,346,203
- OCTAGON CAPITAL ADVISORS LP removed 600,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $7,386,000
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC added 519,000 shares (+145.8%) to their portfolio in Q4 2024, for an estimated $6,388,890
- JPMORGAN CHASE & CO added 482,174 shares (+2251.5%) to their portfolio in Q4 2024, for an estimated $5,935,561
- ADAMS STREET PARTNERS LLC removed 402,847 shares (-26.3%) from their portfolio in Q4 2024, for an estimated $4,959,046
- STEMPOINT CAPITAL LP added 400,101 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,925,243
- ORBIMED ADVISORS LLC removed 391,302 shares (-19.5%) from their portfolio in Q4 2024, for an estimated $4,816,927
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
